Esperion Therapeutics
ESPR
#6169
Rank
NZ$1.53 B
Marketcap
NZ$6.46
Share price
-1.58%
Change (1 day)
8.33%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: NZ$1.53 Billion

As of December 2025 Esperion Therapeutics has a market cap of NZ$1.53 Billion. This makes Esperion Therapeutics the world's 6169th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$1.53 B92.16%
2024NZ$0.79 B48.15%
2023NZ$0.53 B-25.64%
2022NZ$0.72 B62.19%
2021NZ$0.44 B-52.26%
2020NZ$0.93 B-61.64%
2019NZ$2.43 B32.35%
2018NZ$1.83 B-24.26%
2017NZ$2.42 B495.78%
2016NZ$0.40 B-44.34%
2015NZ$0.73 B-30.25%
2014NZ$1.04 B309.35%
2013NZ$0.25 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Esperion Therapeutics was reported to be:

NZ$1.54 Billion
by Nasdaq info icon info icon
NZ$1.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$6.07 B 296.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$17.75 B 1,060.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$256.18 B 16,636.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$131.79 B 8,510.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$5.28 B 245.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$0.88 B-42.47%๐Ÿ‡บ๐Ÿ‡ธ USA